2020 ILADS Annual Conference: Emerging Treatments track (Non-CME)

Courses
2020 ILADS Annual Conferenc...

2020 ILADS Annual Conference: Emerging Treatments track (Non-CME)

The Emerging Treatments and Clinical Pearls track contains 11 recorded presentation slides from the 2020 ILADS Annual Conference.

You may purchase the full day track or each session individually.

Full Track: $350 Non-member/$250 Member

Individual Session: $25 each

After viewing all the videos you may complete the survey to receive a Certificate of Completion. This track does not qualify for CME credit.

$250.00 - $350.00

Purchase

Items Included in the Purchase of this Course

$25.00

Innovative Bartonella Treatments - Clinical Experience Applying Laboratory Research

Presentation: Thomas A. Moorcroft, DO, 23 min 7 sec

Purchase

$25.00

Association between Tick-Borne Illness and Neurodegeneration - A Systematic Review

Presentation: Omar Morales, MD, 20 min 53 sec

Purchase

$25.00

Preventing the Failed Patient

Presentation: Eric Gordon, MD, Nafysa Parpia, ND, 25 min 50 sec

Purchase

$25.00

Synergistic Treatment of COVID-19 with Stem Cells and Peptides

Presentation: Kent A. Holtorf, MD, 20 min 55 sec

Purchase

$25.00

Mast Cell Targeted Treatment in Patients with Tick-borne infections, MCAS and COVID-19

Presentation: Tania T. Dempsey, MD, 30 min 52 sec

Purchase

$25.00

COVID-19: Prevention, Diagnosis, Treatment Options

Presentation: Richard I. Horowitz, MD, 18 min 26 sec

Purchase

$25.00

Emerging Treatments and Clinical Pearls, Faculty Panel Discussion

Presentation: Richard I. Horowitz, MD, Kent A. Holtorf, MD, Eric Gordon, MD, Joseph J. Burrascano Jr., MD, 58 min 40 sec

Purchase

Emerging Treatments Certificate of Completion

Certificate: 0/0 Course items completed

Items Included in the Purchase of this Course

Innovative Bartonella Treatments - Clinical Experience Applying Laboratory Research

Babesiosis and Theileriosis – Update on Current Diagnostic Methods

COVID-19: A Legal Guide to Medical Practitioners in the 2020s

Gestational Lyme Borreliosis… or “Tick Soup”

Lyme & TBD’s in Pregnancy: Risks, Treatment Options

Association between Tick-Borne Illness and Neurodegeneration - A Systematic Review

Preventing the Failed Patient

Synergistic Treatment of COVID-19 with Stem Cells and Peptides

Mast Cell Targeted Treatment in Patients with Tick-borne infections, MCAS and COVID-19

COVID-19: Prevention, Diagnosis, Treatment Options

Emerging Treatments and Clinical Pearls, Faculty Panel Discussion

Emerging Treatments Certificate of Completion